Mark D. Hulett

9.7k total citations · 1 hit paper
127 papers, 7.6k citations indexed

About

Mark D. Hulett is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Mark D. Hulett has authored 127 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 48 papers in Immunology and 24 papers in Cell Biology. Recurrent topics in Mark D. Hulett's work include Glycosylation and Glycoproteins Research (28 papers), Antimicrobial Peptides and Activities (23 papers) and Proteoglycans and glycosaminoglycans research (23 papers). Mark D. Hulett is often cited by papers focused on Glycosylation and Glycoproteins Research (28 papers), Antimicrobial Peptides and Activities (23 papers) and Proteoglycans and glycosaminoglycans research (23 papers). Mark D. Hulett collaborates with scholars based in Australia, United States and United Kingdom. Mark D. Hulett's co-authors include Christopher R. Parish, Ivan K. H. Poon, P. Mark Hogarth, Amy A. Baxter, Thanh Kha Phan, Fung T. Lay, Stephanie Paone, Allison Jones, Suresh Mathivanan and Marilyn A. Anderson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Mark D. Hulett

125 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma

2013 510 citations Christopher G. Adda, Mark D. Hulett et al. profile →

Peers

Countries citing papers authored by Mark D. Hulett

Since Specialization

Citations

This map shows the geographic impact of Mark D. Hulett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Hulett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Hulett more than expected).

Fields of papers citing papers by Mark D. Hulett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Hulett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Hulett. The network helps show where Mark D. Hulett may publish in the future.

Co-authorship network of co-authors of Mark D. Hulett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Hulett. A scholar is included among the top collaborators of Mark D. Hulett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Hulett. Mark D. Hulett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endothelial cell-derived apoptotic bodies modulate innate and adaptive immune responses during inflammation 2025 ·Cell Communication and Signaling ·(unknown), Pamali Fonseka, Emma J. Grant, (unknown), (unknown), (unknown), (unknown), Antony Vinh, Stephanie Paone, Grant R. Drummond, Christopher G. Sobey, Stéphanie Gras, Mark D. Hulett, Suresh Mathivanan, Ivan K. H. Poon, Amy A. Baxter	0
2	Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice 2024 ·Atherosclerosis ·(unknown), Stephanie Paone, Amy A. Baxter, (unknown), Thanh Kha Phan, Enoch Chan, Karlheinz Peter, Ivan K. H. Poon, Shane R. Thomas, Mark D. Hulett	4
3	Effectiveness of an anti-inflammatory diet versus low-fat diet for knee osteoarthritis: the FEAST randomised controlled trial protocol 2024 ·BMJ Open ·(unknown), (unknown), Brooke L. Devlin, Peter Brukner, Joanne L. Kemp, (unknown), Mark D. Hulett, Alysha De Livera, A. Mosler, Hayden G. Morris, (unknown), Adam G Culvenor	5
4	Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption 2023 ·Nature Communications ·Scott A. Williams, Fung T. Lay, (unknown), Suresh Banjara, Ivan K. H. Poon, Thanh Kha Phan, Marc Kvansakul, Mark D. Hulett	7
5	Repurposed inhibitor of bacterial dihydrodipicolinate reductase exhibits effective herbicidal activity 2023 ·Communications Biology ·(unknown), Andrew S. Barrow, Marie‐Claire Giel, Mark D. Hulett, Anthony R. Gendall, Santosh Panjikar, Tatiana P. Soares da Costa	2
6	Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19 2022 ·Nature Communications ·Mirren Charnley, (unknown), (unknown), (unknown), Julian Ratcliffe, Jiangtao Zhou, Raffaele Mezzenga, Mark D. Hulett, (unknown), Joshua T. Berryman, Nicholas P. Reynolds	57
7	Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics 2022 ·Figshare ·(unknown), Marc Kvansakul, Fung T. Lay, Thanh Kha Phan, Mark D. Hulett	21
8	Heparanase: Cloning, Function and Regulation 2020 ·Advances in experimental medicine and biology ·(unknown), Tatiana P. Soares da Costa, Mark D. Hulett	12
9	A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4 2019 ·Scientific Reports ·Paul R. Gilson, (unknown), Jennifer K. Thompson, Xinxin Zhang, Jocelyn Sietsma Penington, (unknown), Hayley E. Bullen, Adele M. Lehane, Madeline G. Dans, Tania F. de Koning‐Ward, Jessica K. Holien, Tatiana P. Soares da Costa, Mark D. Hulett, Melissa J. Buskes, Brendan S. Crabb, Kiaran Kirk, Anthony T. Papenfuss, Alan F. Cowman, Belinda M. Abbott	19
10	Binding of phosphatidic acid by NsD7 mediates the formation of helical defensin–lipid oligomeric assemblies and membrane permeabilization 2016 ·Proceedings of the National Academy of Sciences ·Marc Kvansakul, Fung T. Lay, Christopher G. Adda, Prem K. Veneer, Amy A. Baxter, Thanh Kha Phan, Ivan K. H. Poon, Mark D. Hulett	36
11	Monitoring the progression of cell death and the disassembly of dying cells by flow cytometry 2016 ·Nature Protocols ·Lanzhou Jiang, Rochelle Tixeira, Sarah Caruso, Georgia K. Atkin‐Smith, Amy A. Baxter, Stephanie Paone, Mark D. Hulett, Ivan K. H. Poon	95
12	Convergent evolution of defensin sequence, structure and function 2016 ·Cellular and Molecular Life Sciences ·Thomas Shafee, Fung T. Lay, Thanh Kha Phan, Marilyn A. Anderson, Mark D. Hulett	159
13	Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer 2008 ·Proceedings of the National Academy of Sciences ·Ben Quah, (unknown), Virginia McPhun, Klaus I. Matthaei, Mark D. Hulett, Christopher R. Parish	55
14	Mutagenesis Within Human FcεRIα Differentially Affects Human and Murine IgE Binding 2002 ·The Journal of Immunology ·Graham A. Mackay, Mark D. Hulett, (unknown), Halina M. Trist, Alistair J. Henry, James M. McDonnell, Andrew J. Beavil, Rebecca L. Beavil, Brian J. Sutton, P. Mark Hogarth, Hannah J. Gould	9
15	Heparanase: a key enzyme involved in cell invasion 2001 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Christopher R. Parish, (unknown), Mark D. Hulett	403
16	Identification of Active-Site Residues of the Pro-Metastatic Endoglycosidase Heparanase 2000 ·Biochemistry ·Mark D. Hulett, J. Hornby, Stephen Ohms, Johannes Zuegg, Craig Freeman, Jill E. Gready, Christopher R. Parish	132
17	Monoclonal antibodies and synthetic peptides define the active site of Fc_εRI and a potential receptor antagonist 2000 ·Allergy ·(unknown), Halina M. Trist, (unknown), Mark D. Hulett, P. Mark Hogarth, (unknown), V. Chandana Epa	15
18	Fine structure analysis of the interaction of FceRI with IgE 1999 ·Journal of Biological Chemistry ·Mark D. Hulett, Ewa Witort, Ross I. Brinkworth, Ian F. C. McKenzie, P. Mark Hogarth	1
19	Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. 1999 ·Nature Structural Biology ·P. Mark Hogarth, (unknown), Maree S. Powell, Mark D. Hulett, Peter Bartoň, Ian F. C. McKenzie, Thomas Garrett	154
20	Redirected Cytotoxic Effector Function 1996 ·Journal of Biological Chemistry ·Michael H. Kershaw, Phillip K. Darcy, Mark D. Hulett, P. Mark Hogarth, Joseph A. Trapani, Mark J. Smyth	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact